RPID

Rapid Micro Biosystems, Inc. Class A Common Stock

0.62

USD

0.00

+0.16%

Nov 06, 11:50 UTC -5

Open

Rapid Micro Biosystems, Inc. Class A Common Stock (RPID) Earnings

RPID Earnings Reports

Positive Surprise Ratio

RPID beat 8 of 21 last estimates.

38%

Next Report

Date of Next Report

Mar 10, 2027

Estimate for Q4 26 (Revenue/ EPS)

$13.61M

-$0.16

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

+20.61%

-42.86%

Rapid Micro Biosystems, Inc. Class A Common Stock earnings per share and revenue

On Nov 05, 2026, RPID reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.20 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 10.08 million, with a --% difference.

Looking ahead to Q4 26, -- analysts forecast an EPS of -0.16 USD, with revenue projected to reach 13.61 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

Mettler-Toledo International

Report Date

Nov 05, 2026 For Q3 26

Estimate

$12.21

Actual

$12.57

Surprise

+2.90%

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

Pulse Biosciences, Inc Common Stock (DE)

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.32

Surprise

+14.05%

TransMedics Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.29

Actual

$0.51

Surprise

+71.31%

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Treace Medical Concepts, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.67%

Inogen Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.56

Surprise

-285.41%

FAQ

What were Rapid Micro Biosystems, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Rapid Micro Biosystems, Inc. Class A Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Rapid Micro Biosystems, Inc. Class A Common Stock's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Rapid Micro Biosystems, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Mar 10, 2027.

What are the forecasts for Rapid Micro Biosystems, Inc. Class A Common Stock's next earnings report?

Based on -- analysts, Rapid Micro Biosystems, Inc. Class A Common Stock is expected to report EPS of -$0.16 and revenue of $13.61M for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.